miRNA COVID-19 Severity Linked to mRNA, lncRNA Signature in Blood The researchers said that more research into these biomarkers could help with patient stratification and therapy selection. Singapore's MiRxes Sets Out to Sell Gastric Cancer Test Across Asia Premium The assay underwent clinical validation at three centers in Singapore and 5,248 patients were ultimately screened using the test. Summit Biolabs Commercializing Tests for Head and Neck Cancer Recurrence, COVID-19 Premium The firm's platform, dubbed HNKlear, uses methylation-specific PCR to detect microRNA biomarkers in a patient's blood sample following frontline cancer treatment. Quadrant Biosciences Wins $2.3M NIH Grant to Develop Saliva Test for Concussion The company and its collaborators previously published a study linking saliva concentrations of multiple microRNAs with concussion duration and symptoms in children. Integrated Proteomic Papers Define Lung Cancer Features Across Populations, Smoking Histories Three research teams profiled proteomic, genomic, and other features in lung adenocarcinomas in Asia and other parts of the world, including cases in never-smokers. May 11, 2020 Genetic Ancestry Linked to Differences in Molecular Features of Cancers Apr 6, 2020 MiR Scientific Validates Urine-Based Cancer Tests, Awaits NY State Approval Premium Mar 5, 2020 Blood-Based MicroRNA Signatures Can Distinguish Individuals With Lung Cancer Dec 18, 2019 ALS Genomic Analysis Highlights Potential MicroRNA Contributor Nov 21, 2019 DiamiR Wins $492K Grant for Alzheimer's Disease Dx Research Oct 10, 2019 FYR Diagnostics Wins $618K NIH Grant to Develop Acquired Epilepsy Assay Sep 30, 2019 Interpace Diagnostics Signs Thyroid Cancer Test Coverage Deals With Three BCBS Plans Sep 19, 2019 Inex Innovate to Launch New Molecular Tests for Ovarian Cancer, Breast Cancer in Asia Premium Sep 16, 2019 Alzheimer's Disease Test Firm DiamiR Awarded Additional $345K From NIA Aug 29, 2019 Notre Dame Team Wins $2.9M NIH Grant for ExRNA Analysis Platform Aug 13, 2019 Interpace Diagnostics Q2 Revenues Climb 14 Percent Jul 30, 2019 Pan-Cancer Study Uncovers TP53 Mutation Consequences, Related Prognostic Expression Signature Jul 16, 2019 Arcis Licenses Sample Prep Technology to microRNA Diagnostics Firm Mirnax Biosens Jul 12, 2019 Avalon GloboCare Using Exosome Isolation Platform to Pursue Oral Cancer Dx, Rx Applications Premium Jul 2, 2019 Noninvasive Endometriosis Test Developer DotLab Secures $10M in Series A Funding Jun 17, 2019 Q BioMed Using MicroRNA Biomarkers to Guide Therapy Development in Subset of Autism Patients Premium Apr 25, 2019 Colon Cancer Biology, Treatment Clues Found in Proteogenomic Analysis Mar 28, 2019 MiR Scientific Prepares to Launch Tests for Prostate, Bladder Cancer Premium Mar 12, 2019 HeiScreen Preps Liquid Biopsy Breast Cancer Test for Year-End Launch Premium Jan 14, 2019 Tumor Hypoxia Associated With Cancer Driver Mutation Signatures in 19 Tumor Types Load More Breaking News Sequencing Study Uncovers MERS-Related Coronavirus in Swiss Bats Angstrom Bio Raises $3M in Private Financing Eagle Biosciences, Genetic Analysis Ink Distribution Agreement for Gut Microbiota Test Centogene Q1 Revenues Grow More Than Fivefold Driven by COVID-19 Testing Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel The Scan CDC Calls Delta "Variant of Concern" CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern." From FDA to Venture Capital Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post. Consent Questions Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles. Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.